Rare Genetic Mutation Linked to Accelerated Aging & Neurological Decline
Rare Genetic Mutation Linked to Accelerated Aging and Neurological Decline
A rare and previously unknown genetic mutation is causing a rapid onset of aging and neurological deterioration in adolescents, according to a study released by the Sanford Burnham Prebys Medical Institute. The findings, published in the journal Nature Communications, pinpoint a defect in cellular division that transforms healthy cells into a dormant state known as cellular senescence, contributing to premature graying and rapid neurological decline.
Researchers detailed how the mutation impacts the fundamental process of cell division, effectively turning viable cells into what they describe as “zombie cells.” These senescent cells accumulate and disrupt normal tissue function, accelerating the aging process and causing significant cognitive and motor skill impairment.
The international research team utilized advanced genomic sequencing and mapping techniques to connect the emerging disease to a sudden mutation in a gene scientifically designated IVNS1ABP. “This allowed us to pinpoint the root causes behind this mysterious deterioration,” stated Dr. Su Chun Chang, director of the institute’s Center for Neurological Diseases, according to Medical Xpress.
To further investigate, researchers extracted skin cells from affected patients and reprogrammed them into neural stem cells carrying the same mutation. This allowed them to observe the cells’ behavior under a microscope. Dr. Fang Yuan, the lead researcher, noted that the gene had not previously been linked to age-related diseases or neurological disorders, making its role in this condition a significant scientific puzzle.
The laboratory observations revealed that the neural cells carrying the mutation grew at an extremely slow rate and entered cellular senescence due to continuous and severe damage to their DNA during attempted division. Researchers observed elevated levels of the CDKN2A gene, which is associated with halting the cell cycle. Crucially, the problem was identified as centering on actin proteins, responsible for forming the structural support system for cell division.
“The actin ring in the mutated cells takes on a distorted and contracted shape, preventing symmetrical cell division and leading to cell damage,” explained Dr. Chang. This finding provides a key scientific explanation for the rapid physical and mental deterioration observed in patients with the condition.
Initial experiments have shown promising results, with specific chemical compounds successfully stabilizing the actin structure and improving normal cell division rates. “Correcting some of the steps in the molecular processes has demonstrably repaired the defects within the cell model,” stated Dr. Yuan, adding that the team is preparing to apply these findings to animal models currently under development to ensure efficacy.
The discovery highlights the power of combining stem cell technology with genetic analysis, not only for identifying previously unknown diseases but likewise for laying the groundwork for targeted therapeutic interventions. As of Wednesday, March 25, 2026, the institute has not announced plans for human clinical trials.